Prestige Consumer Healthcare (NYSE:PBH) Given New $72.00 Price Target at Oppenheimer

Prestige Consumer Healthcare (NYSE:PBH) had its price objective lowered by Oppenheimer from $82.00 to $72.00 in a research report released on Tuesday, MarketBeat Ratings reports. The brokerage currently has an outperform rating on the stock.

Other equities analysts have also issued reports about the company. Canaccord Genuity Group decreased their target price on Prestige Consumer Healthcare from $105.00 to $100.00 and set a “buy” rating on the stock in a research note on Friday, August 8th. Weiss Ratings restated a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research note on Wednesday, October 8th. Sidoti upgraded Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 target price on the stock in a research note on Wednesday, September 24th. Wall Street Zen lowered Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Finally, Zacks Research lowered Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research note on Thursday, September 4th. Four research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Prestige Consumer Healthcare presently has a consensus rating of “Hold” and an average price target of $90.60.

Prestige Consumer Healthcare Stock Performance

Shares of PBH opened at $62.56 on Tuesday. The stock’s 50-day simple moving average is $64.22 and its 200 day simple moving average is $75.01. The stock has a market capitalization of $3.08 billion, a price-to-earnings ratio of 14.69, a price-to-earnings-growth ratio of 1.97 and a beta of 0.44. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. Prestige Consumer Healthcare has a 52-week low of $60.15 and a 52-week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last announced its earnings results on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing analysts’ consensus estimates of $1.01 by ($0.06). The business had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.Prestige Consumer Healthcare’s revenue was down 6.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.90 earnings per share. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. Research analysts forecast that Prestige Consumer Healthcare will post 4.5 EPS for the current fiscal year.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Several institutional investors have recently modified their holdings of PBH. UMB Bank n.a. increased its position in shares of Prestige Consumer Healthcare by 81.8% during the 2nd quarter. UMB Bank n.a. now owns 320 shares of the company’s stock valued at $26,000 after purchasing an additional 144 shares during the last quarter. Caitong International Asset Management Co. Ltd increased its position in shares of Prestige Consumer Healthcare by 312.5% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 330 shares of the company’s stock valued at $26,000 after purchasing an additional 250 shares during the last quarter. Maseco LLP bought a new position in Prestige Consumer Healthcare during the 2nd quarter worth approximately $27,000. Elevation Point Wealth Partners LLC bought a new position in Prestige Consumer Healthcare during the 2nd quarter worth approximately $46,000. Finally, First Horizon Advisors Inc. grew its position in Prestige Consumer Healthcare by 294.1% during the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the company’s stock worth $48,000 after acquiring an additional 447 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.